Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Extendicare Inc

Healthcare CA EXE

26.64CAD
0.46(1.76%)

Last update at 2026-03-10T20:00:00Z

Day Range

26.0426.80
LowHigh

52 Week Range

10.2324.86
LowHigh

Fundamentals

  • Previous Close 26.18
  • Market Cap2286.83M
  • Volume241509
  • P/E Ratio22.84
  • Dividend Yield2.07%
  • EBITDA149.88M
  • Revenue TTM1589.94M
  • Revenue Per Share TTM18.82
  • Gross Profit TTM 227.52M
  • Diluted EPS TTM1.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 99.86M 44.80M -4.49600M 16.04M 58.87M
Minority interest - - - - -
Net income 75.21M 33.98M -4.51100M 9.01M 42.59M
Selling general administrative 1199.50M 55.84M 1164.12M 1140.20M 48.96M
Selling and marketing expenses - 1032.78M - - -
Gross profit 168.00M 167.62M 1221.58M 1216.76M 1158.29M
Reconciled depreciation 33.34M 32.23M 32.12M 38.57M 38.80M
Ebit 121.94M 66.41M 20.99M 56.62M 93.30M
Ebitda 155.27M 98.63M 53.11M 95.19M 132.10M
Depreciation and amortization 33.34M 32.23M 32.12M 38.57M 38.80M
Non operating income net other - - - - -
Operating income 111.21M 62.96M 20.99M 56.62M 93.30M
Other operating expenses 1354.99M 1242.37M 1196.91M 1162.01M 1063.95M
Interest expense 21.10M 21.60M 20.61M 27.20M 28.48M
Tax provision 24.65M 10.82M 0.01M 7.03M 16.28M
Interest income 13.11M 6.19M 15.52M 23.74M 28.97M
Net interest income -15.73500M -15.49300M -15.28200M -25.03200M -27.03400M
Extraordinary items - 0.00000M 74.06M 2.49M 11.60M
Non recurring - - - - -
Other items - - - - -
Income tax expense 24.65M 10.82M 0.01M 7.03M 16.28M
Total revenue 1466.20M 1304.96M 1221.58M 1216.76M 1158.29M
Total operating expenses 56.94M 55.84M 1196.91M 1162.01M 1063.95M
Cost of revenue 1298.21M 1137.34M 1113.05M 1070.41M 976.20M
Total other income expense net -11.35200M -18.15900M -25.48300M -40.58000M -34.43100M
Discontinued operations - - 74.06M 2.49M 11.60M
Net income from continuing ops 75.21M 33.98M -4.51100M 9.01M 42.59M
Net income applicable to common shares 75.21M 33.98M 69.55M 11.50M 54.19M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 719.79M 672.73M 781.58M 900.32M 963.13M
Intangible assets 75.06M 78.46M 51.21M 46.63M 36.50M
Earning assets - - - - -
Other current assets 28.82M 20.20M 23.98M 26.47M 40.23M
Total liab 595.44M 584.81M 680.88M 798.40M 834.94M
Total stockholder equity 124.35M 87.92M 100.70M 101.92M 128.19M
Deferred long term liab - - - - -
Other current liab - 3.25M 5.61M 15.34M 21.06M
Common stock - 467.35M 475.42M 500.88M 500.58M
Capital stock 469.33M 467.35M 475.42M 500.88M 500.58M
Retained earnings -352.54600M -393.47100M -384.62000M -402.45300M -370.96300M
Other liab - - 41.16M 52.48M 59.64M
Good will 45.85M 45.85M 45.85M 45.85M 51.67M
Other assets - 0.00000M 37.76M 47.32M 52.96M
Cash 121.85M 75.91M 167.28M 104.63M 179.96M
Cash and equivalents - - 167.28M 104.63M 179.96M
Total current liabilities 292.88M 226.39M 274.99M 281.91M 279.52M
Current deferred revenue - - - - -
Net debt 170.64M 258.60M 216.69M 432.22M 384.64M
Short term debt - 19.88M 19.24M 73.58M 71.39M
Short long term debt 31.09M 19.88M 19.24M 73.58M 71.39M
Short long term debt total - 334.52M 383.97M 536.85M 564.60M
Other stockholder equity - 13.09M 17.70M 15.27M 12.00M
Property plant equipment - - 388.72M 535.60M 525.90M
Total current assets 243.70M 187.14M 258.04M 224.92M 296.08M
Long term investments 24.75M 24.53M - - -
Net tangible assets - - 3.64M 9.44M 40.01M
Short term investments - - - - -
Net receivables 88.74M 91.03M 64.07M 83.54M 73.39M
Long term debt 261.39M 314.64M 364.74M 463.27M 493.21M
Inventory - - 2.70M 10.29M 2.51M
Accounts payable 241.50M 203.26M 250.14M 192.99M 187.07M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.96M -7.79800M -11.76800M -13.42700M
Additional paid in capital - - - - -
Common stock total equity - - - - 500.58M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 29.43M 34.98M 30.47M 32.89M 37.13M
Deferred long term asset charges - - - - -
Non current assets total 476.09M 485.59M 523.54M 675.40M 667.04M
Capital lease obligations - - - - -
Long term debt total - - 364.74M 463.27M 493.21M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -9.11100M -84.45300M 155.64M -63.73300M 2.00M
Change to liabilities - - 48.62M 15.45M 49.85M
Total cashflows from investing activities -9.11100M -84.45300M 155.64M -63.73300M 2.00M
Net borrowings -44.53400M 18.67M -114.22900M -29.98200M 6.96M
Total cash from financing activities -87.86600M -30.92800M -191.85900M -74.83600M -38.16300M
Change to operating activities - - 1.40M 11.95M -19.85500M
Net income 75.21M 33.98M 69.55M 11.50M 54.19M
Change in cash 46.66M -92.09700M 62.65M -75.32900M 85.50M
Begin period cash flow 75.18M 167.28M 104.63M 179.96M 94.46M
End period cash flow 121.85M 75.18M 167.28M 104.63M 179.96M
Total cash from operating activities 143.64M 23.28M 98.71M 63.42M 121.27M
Issuance of capital stock - - - - -
Depreciation 33.34M 32.59M 32.12M 38.57M 38.80M
Other cashflows from investing activities 3.37M 44.96M 257.27M 5.79M 35.10M
Dividends paid -40.02000M -40.43200M 42.55M 42.99M 41.26M
Change to inventory - - - - -
Change to account receivables -3.58300M -29.20000M 4.04M -13.76500M -7.94600M
Sale purchase of stock 0.00000M -11.05600M -35.02300M - -
Other cashflows from financing activities -3.31200M 1.89M 1.31M 0.48M 58.50M
Change to netincome - - -57.02500M -0.28300M 6.23M
Capital expenditures 41.95M 129.41M 101.63M 69.52M 33.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 22.85M -41.19500M 54.06M 13.63M 22.05M
Stock based compensation 1.89M 4.20M 2.64M 3.57M 2.00M
Other non cash items -13.50600M -10.30700M -59.61900M -10.45900M -12.34800M
Free cash flow 101.69M -106.12900M -2.91500M -6.09900M 88.17M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EXE
Extendicare Inc		 0.46 1.76% 26.64 22.84 21.74 1.44 13.77 1.53 13.80
SIA
Sienna Senior Living Inc		 0.02 0.09% 23.05 50.39 38.02 2.16 3.33 3.42 22.17
WELL
WELL Health Technologies Corp		 -0.09 2.04% 4.33 - 10.52 0.79 1.23 1.23 13.24
DR
Medical Facilities Corporation		 -0.17 1.00% 16.80 6.14 9.86 0.89 2.50 0.70 3.08
CRRX
CareRx Corp		 -0.04 1.10% 3.60 390.00 20.00 0.67 2.81 0.85 11.90

Reports Covered

Stock Research & News

View All

Profile

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Extendicare Inc

3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9

Key Executives

Name Title Year Born
Dr. Michael R. Guerriere M.D., MBA CEO, Pres & Director 1964
Mr. David E. Bacon Sr. VP & CFO NA
Mr. John Toffoletto Sr. VP, Chief Legal Officer & Corp. Sec. NA
Ms. Leslie Sarauer Sr. VP & Chief HR Officer 1962
Mr. Ali Mohammad Mir VP, ParaMed Operations NA
Mr. Steve Paraskevopoulos Sr. VP of ParaMed & CTO NA
Ms. Jillian E. Fountain VP of Investor Relations NA
Ms. Lisa Pearson VP of Public Affairs NA
Ms. Elaine E. Everson VP of Corp. Devel. NA
Dr. Matthew Morgan Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.